Efficacy and Safety of Carbapenems vs New Antibiotics for Treatment of Adult Patients With Complicated Urinary Tract Infections: A Systematic Review and Meta-analysis.

Open Forum Infect Dis · 2022 · PMC9031024 · PMID 35474756

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

We identified no significant difference between the new treatments examined and the carbapenem comparator for the composite measure of clinical and microbiological cure, though a favorable trend toward the new treatments was observed (RR, 0.91; 95% CI, 0.79–1.04).

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.